Trim14−/− mice were developed by MMRRC at UC Davis using CRISPR Cas9 gene editing to constitutively delete exon 3–4 and flanking splicing regions in mouse zygotes (MMRC stock #043885-UCD)
DOI: 10.64898/2026.06.26.734825
Resource: RRID:MMRRC_043885-UCD
Curator: @AleksanderDrozdz
SciCrunch record: RRID:MMRRC_043885-UCD